Brief Description
Redwood Bioscience, Inc. develops a protein-chemical engineering technology to produce antibody-drug conjugates and other semi-synthetic biotherapeutics. The company offers SMARTag site-specific protein modification and cytotoxin-linker technologies that enable the generation of homogenous bioconjugates engineered to enhance potency, safety, and stability. Its SMARTag platform provides precise payload positioning and defined stoichiometry of payload-protein ratios. The company was incorporated in 2008 and is based in Emeryville, California. Redwood Bioscience, Inc. operates as a subsidiary of Catalent, Inc.
The company was co-founded by UC Berkeley Professor of Chemistry Carolyn Bertozzi and David Rabuka, who was a PhD student in her lab. In 2022, Dr. Bertozzi shared the Nobel Prize in Chemistry.
Redwood Bioscience was acquired by Catalent Pharma Solutions in 2014.
Timeline
- 2008. Company founded
- 2014. Company acquired by Catalent Pharma Solutions (NYSE: CTLT)
Inventors
Carolyn Bertozzi, Brian Carlson, Peng Wu, Isaac Carrico, and Jason Rush